Drugs built against specific biomarkers hsCRP and Lp(a) both failed to reduce the number of heart attacks and strokes, in recent clinical trials. Cardiovascular medicine teaches us again and again that the interventions with the best evidence are still the boring ones: eat well, move, don’t smoke, stay lean